| scholarly article | Q13442814 |
| P2093 | author name string | Deng J | |
| Chang L | |||
| Stanczyk FZ | |||
| Hsing AW | |||
| Gao YT | |||
| Chua S Jr | |||
| Gentzschein E | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 783-789 | |
| P577 | publication date | 2001-05-01 | |
| P1433 | published in | Journal of the National Cancer Institute | Q400279 |
| P1476 | title | Prostate cancer risk and serum levels of insulin and leptin: a population-based study | |
| P478 | volume | 93 |
| Q33806363 | A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival |
| Q57200700 | A Multi-country Ecological Study of Dietary Risk and Risk-reduction Factors for Prostate Cancer |
| Q34793975 | A polymorphism in the glucokinase gene that raises plasma fasting glucose, rs1799884, is associated with diabetes mellitus and prostate cancer: findings from a population-based, case-control study (the ProtecT study). |
| Q50055076 | A stage-dependent link between metabolic syndrome components and incident prostate cancer |
| Q49486668 | A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus |
| Q33889825 | Adipokine genes and prostate cancer risk |
| Q92419678 | Appetite-regulating hormones-leptin, adiponectin and ghrelin-and the development of prostate cancer: a systematic review and exploratory meta-analysis |
| Q46664302 | Association between BMI and metabolic syndrome and adenomatous colonic polyps in Korean men. |
| Q34203868 | Association between C-Peptide Concentration and Prostate Cancer Incidence in the CLUE II Cohort Study |
| Q46399292 | Association between prostate-specific antigen and leptin, adiponectin, HbA1c or C-peptide among African-American and Caucasian men. |
| Q34807637 | Association of 17 prostate cancer susceptibility loci with prostate cancer risk in Chinese men. |
| Q33640049 | Association of C-peptide and leptin with prostate cancer incidence in the Health Professionals Follow-up Study |
| Q46879124 | Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts |
| Q44769689 | Association of prostate cancer risk with insulin, glucose, and anthropometry in the Baltimore longitudinal study of aging |
| Q42371605 | BMI and serum lipid parameters predict increasing risk and aggressive prostate cancer in Chinese people |
| Q34535741 | Benign prostatic hyperplasia is a significant risk factor for bladder cancer in diabetic patients: a population-based cohort study using the National Health Insurance in Taiwan. |
| Q63966079 | Blood glucose, glucose balance, and disease-specific survival after prostate cancer diagnosis in the Finnish Randomized Study of Screening for Prostate Cancer |
| Q33894539 | Body mass index affects the diagnosis and progression of prostate cancer in Hispanics |
| Q36303735 | Body mass index and renal cell cancer: the influence of race and sex. |
| Q34132305 | Bone marrow fat: linking adipocyte-induced inflammation with skeletal metastases |
| Q34713132 | Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis |
| Q36021067 | Changing trends of prostate cancer in Asia. |
| Q42971655 | Clinical outcomes after radical prostatectomy in diabetic patients treated with metformin |
| Q35611822 | Coffee consumption and risk of nonaggressive, aggressive and fatal prostate cancer--a dose-response meta-analysis |
| Q39100263 | Construction of a lncRNA-PCG bipartite network and identification of cancer-related lncRNAs: a case study in prostate cancer |
| Q36251554 | Defining the Molecular Nexus of Cancer, Type 2 Diabetes and Cardiovascular Disease |
| Q50775642 | Diabetes and benign prostatic hyperplasia progression in Olmsted County, Minnesota. |
| Q39852959 | Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. |
| Q37187103 | Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study |
| Q53108925 | Diabetes mellitus and risk of prostate cancer: an updated meta-analysis based on 12 case-control and 25 cohort studies. |
| Q35927069 | Diabetes treatment and progression of benign prostatic hyperplasia in community-dwelling black and white men. |
| Q82953724 | Diet, physical activity and energy balance and their impact on breast and prostate cancers |
| Q37251457 | Dietary soy and tea combinations for prevention of breast and prostate cancers by targeting metabolic syndrome elements in mice |
| Q36060809 | Difference in Association of Obesity With Prostate Cancer Risk Between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT). |
| Q36732591 | Differential effects of leptin on the invasive potential of androgen-dependent and -independent prostate carcinoma cells |
| Q90183048 | Discovering genetic interactions bridging pathways in genome-wide association studies |
| Q52651276 | Does a prostate cancer diagnosis affect management of pre-existing diabetes? Results from PCBaSe Sweden: a nationwide cohort study. |
| Q34825681 | Effect of acute exercise on prostate cancer cell growth |
| Q57433696 | Environmentally Induced Alterations in the Epigenome Affecting Obesity and Cancer in Minority Populations |
| Q35098158 | Epidemiological study of prostate cancer (EPICAP): a population-based case-control study in France |
| Q36598326 | Examining the relationship between obesity and prostate cancer. |
| Q40600607 | Exercise alters the IGF axis in vivo and increases p53 protein in prostate tumor cells in vitro |
| Q37355770 | Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention Trial |
| Q37315673 | Fish oil slows prostate cancer xenograft growth relative to other dietary fats and is associated with decreased mitochondrial and insulin pathway gene expression. |
| Q34732880 | Hormones and prostate cancer: current perspectives and future directions |
| Q46875718 | Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy |
| Q46875485 | ICAM gene cluster SNPs and prostate cancer risk in African Americans. |
| Q35966836 | Impact of body mass index on biochemical recurrence rates after radical prostatectomy: an analysis utilizing propensity score matching |
| Q39980615 | Impact of diabetes mellitus on the detection of prostate cancer via contemporary multi (≥ 12)-core prostate biopsy |
| Q79883844 | Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer |
| Q39437898 | Insulin prevents leptin inhibition of RM1 prostate cancer cell growth |
| Q37434345 | Insulin resistance and hyperinsulinaemia in the development and progression of cancer |
| Q44267699 | Insulin resistance and prostate cancer risk |
| Q37750283 | Insulin--carcinogen or mitogen? Preclinical and clinical evidence from prostate, breast, pancreatic, and colorectal cancer research |
| Q36589091 | Insulin-like growth factors and insulin-like growth factor-binding proteins and prostate cancer risk: results from the prostate cancer prevention trial |
| Q51541991 | Insulin-like growth factors and risk of benign prostatic hyperplasia. |
| Q51806440 | Intermittent calorie restriction delays prostate tumor detection and increases survival time in TRAMP mice. |
| Q42590351 | Is central obesity, hyperinsulinemia and dyslipidemia associated with high-grade prostate cancer? A descriptive cross-sectional study |
| Q34547866 | Is there a role for a low-carbohydrate ketogenic diet in the management of prostate cancer? |
| Q35763096 | Lifestyle recommendations to prevent prostate cancer, part I: time to redirect our attention? |
| Q34794028 | Metabolic imbalance and prostate cancer progression. |
| Q24631619 | Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link |
| Q42700292 | Metformin: A Bridge between Diabetes and Prostate Cancer. |
| Q42956899 | Nutrients and risk of prostate cancer |
| Q37885642 | Nutrigenetics and prostate cancer: 2011 and beyond |
| Q52662023 | Obesity and Cancer: Existing and New Hypotheses for a Causal Connection. |
| Q50856725 | Obesity and Prostate Cancer. |
| Q81550807 | Obesity and prostate cancer |
| Q36810924 | Obesity, energy balance, and cancer: new opportunities for prevention |
| Q58216794 | Peroxisome Proliferator-Activated Receptor-γ Polymorphism, Body Mass and Prostate Cancer Risk: Evidence for Gene-Environment Interaction |
| Q38387928 | Physical activity and its mechanistic effects on prostate cancer |
| Q36135601 | Plasma Leptin Levels and Risk of Incident Cancer: Results from the Dallas Heart Study. |
| Q46300666 | Polymorphism in IGF-2 as a surrogate marker for predisposition towards tobacco chewing-mediated oral cancer |
| Q36648747 | Polymorphism of the insulin gene is associated with increased prostate cancer risk |
| Q34845451 | Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis |
| Q35178839 | Prediagnostic plasma IGFBP-1, IGF-1 and risk of prostate cancer |
| Q38342105 | Prostate cancer cell proliferation and angiogenesis in different obese mice models |
| Q73138981 | Prostate cancer epidemiology |
| Q43620190 | Prostate cancer mortality in Taiwanese men: increasing age-standardized trend in general population and increased risk in diabetic men. |
| Q43236600 | Prostate cancer, insulin, and androgen deprivation therapy |
| Q35012809 | Prostate cancer: another aspect of the insulin-resistance syndrome? |
| Q80993664 | Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin |
| Q42610545 | Prostate carcinoma risk subsequent to diagnosis of benign prostatic hyperplasia: a population-based cohort study in Sweden |
| Q34756939 | Racial variation in umbilical cord blood leptin concentration in male babies |
| Q37462502 | Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer |
| Q36375316 | Risk factors for the onset of prostatic cancer: age, location, and behavioral correlates |
| Q81253609 | Risk of prostate cancer and family history of cancer: a population-based study in China |
| Q34764764 | Role of hormonal and other factors in human prostate cancer |
| Q40126811 | Serum Insulin, Glucose, Indices of Insulin Resistance, and Risk of Lung Cancer |
| Q36624148 | Serum insulin level, disease stage, prostate specific antigen (PSA) and Gleason score in prostate cancer |
| Q46417781 | Serum levels of leptin, insulin, and lipids in relation to breast cancer in china |
| Q37237661 | Soluble FAS ligand as a biomarker of disease recurrence in differentiated thyroid cancer |
| Q90253109 | Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen |
| Q37427949 | The Impact of Diabetes on the Risk of Prostate Cancer Development according to Body Mass Index: A 10-year Nationwide Cohort Study |
| Q33986252 | The aryl hydrocarbon receptor (AhR) inhibits vanadate-induced vascular endothelial growth factor (VEGF) production in TRAMP prostates |
| Q39858236 | The association between metabolic syndrome and prostate-specific antigen levels |
| Q47379977 | The dark side of glucose transporters in prostate cancer: Are they a new feature to characterize carcinomas? |
| Q37173979 | The effects of varying dietary carbohydrate and fat content on survival in a murine LNCaP prostate cancer xenograft model |
| Q36834176 | The impact of obesity on prostate cancer |
| Q34674114 | The leptin gene family and colorectal cancer: interaction with smoking behavior and family history of cancer |
| Q36339823 | The link between obesity and prostate cancer: the leptin pathway and therapeutic perspectives |
| Q37910709 | Urological aspects of the metabolic syndrome |
| Q81557071 | Variants in circadian genes and prostate cancer risk: a population-based study in China |
| Q53596040 | Visceral fat accumulation as a risk factor for prostate cancer. |
| Q51377592 | Visceral obesity and inflammation markers in relation to serum prostate volume biomarkers among apparently healthy men. |
Search more.